12 months from date of receipt / reconstitution, 2 to 8 °C as supplied
稀释度
背景介绍
Denosumab is a human monoclonal antibody against RANKL used for the treatment of osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone.